HCW Biologics Inc. (HCWB)

HCW Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.95	4.67	3.6	22.33	11.73
Short-Term Investments	-	-	-	9.74	24.98
Cash & Short-Term Investments	1.95	4.67	3.6	32.06	36.71
Cash Growth	-58.23%	30.03%	-88.79%	-12.67%	334.19%
Accounts Receivable	0.03	0.58	1.54	0.42	0.13
Other Current Assets	0.3	0.44	1.27	1.59	3.63
Total Current Assets	2.28	5.7	6.4	34.07	40.48
Net Property, Plant & Equipment	20.88	22.91	20.45	10.8	1.12
Long-Term Investments	1.33	1.6	1.6	1.6	11.52
Other Long-Term Assets	0.03	0.03	0.06	0.33	0.39
Total Assets	24.52	30.24	28.51	46.81	53.51
Accounts Payable	13.14	22.33	6.17	1.23	0.22
Accrued Expenses	1.11	0.98	2.58	1.73	2.1
Short-Term Debt	6.81	6.31	-	-	-
Total Current Liabilities	21.06	29.63	8.75	2.96	2.32
Long-Term Debt	-	7.38	6.3	6.41	-
Other Long-Term Liabilities	0.69	-	-	0.01	-
Total Long-Term Liabilities	0.69	7.38	6.3	6.42	-
Total Liabilities	21.76	37.01	15.05	9.38	2.32
Common Stock	0	0	0	0	0
Additional Paid-in Capital	111.28	93.79	83.99	82.96	81.83
Retained Earnings	-108.52	-100.56	-70.53	-45.54	-30.64
Total Common Shareholders' Equity	2.76	-6.77	13.46	37.43	51.19
Shareholders' Equity	2.76	-6.77	13.46	37.43	51.19
Total Liabilities & Equity	24.52	30.24	28.51	46.81	53.51
Total Debt	6.81	13.69	6.3	6.41	0
Net Cash (Debt)	-4.86	-9.02	-2.71	25.65	36.71
Net Cash Growth	-	-	-	-30.13%	334.19%
Net Cash Per Share	-2.31	-9.30	-3.02	28.64	78.24
Book Value	2.76	-6.77	13.46	37.43	51.19
Book Value Per Share	1.32	-6.98	14.99	41.79	109.09
Tangible Book Value	2.76	-6.77	13.46	37.43	51.19
Tangible Book Value Per Share	1.32	-6.98	14.99	41.79	109.09

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q